The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Exclusive Q&A with Dr. Hearn Jay Cho, Mt. Sinai Hospital, NY, NY

A promising avenue of clinical research in multiple myeloma is the use of immune checkpoint inhibitors. As most myeloma patients know, there is a constant need for multiple agents, with new mechanisms of actions to treat relapsed and refractory patients. We spoke with Dr. Hearn Jay Cho from Mt. Sinai Hospital. READ MORE

Posted: June 20, 2016

MMRF Holds CoMMpass Collaborator Meetings at ASCO 2016

On Saturday June 4 at ASCO, the MMRF Research Team met with our CoMMpass trial collaborators to discuss the current status of the trial and new directions for CoMMpass in the near future. READ MORE

Posted: June 20, 2016

MULTIPLE MYELOMA RESEARCH FOUNDATION (MMRF) FOUNDER KATHY GIUSTI TO CO-CHAIR HARVARD BUSINESS SCHOOL/KRAFT PRECISION MEDICINE ACCELERATOR

The Multiple Myeloma Research Foundation (MMRF), a leader in precision medicine, today announced that its founder, Kathy Giusti, whom Fortune recently named as one of three business leaders who are disrupting medicine, has been appointed faculty co-chair of the Kraft Precision Medicine Accelerator at Harvard Business School (HBS). READ MORE

Posted: June 13, 2016

Page 23 of 87« First...10...2122232425...304050...Last »